Published in Pediatr Nephrol on November 21, 2007
NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res (2005) 17.61
TGF-beta signaling and the fibrotic response. FASEB J (2004) 9.81
Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol (2005) 7.54
All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci (2006) 5.18
Nephropathy in diabetes. Diabetes Care (2004) 4.08
Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J (1999) 3.28
The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. Diabetes (2002) 3.00
Epidemiology of chronic renal failure in children: data from the ItalKid project. Pediatrics (2003) 2.49
Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem (2003) 2.35
Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl (2000) 1.87
Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci U S A (1998) 1.86
The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol (2003) 1.80
The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes (2002) 1.79
The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67
Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol (2003) 1.56
Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care (1999) 1.44
Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia (1975) 1.27
Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol (2004) 1.26
Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc Soc Exp Biol Med (1997) 1.21
Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy. Endocrinology (2004) 1.13
Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol (2004) 1.12
High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol (1999) 1.11
Relationship between early metabolic control and the development of microalbuminuria--a longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1993) 1.05
Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol (1989) 1.02
The v-myc oncogene. Oncogene (1999) 0.97
Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J Gerontol A Biol Sci Med Sci (2006) 0.97
Long-term prognosis of renal function in boys treated for posterior urethral valves. Eur J Pediatr Surg (1999) 0.95
Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin. Cell Signal (2000) 0.93
Follistatins: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol (1993) 0.93
Inhibins, activins, and follistatins: the saga continues. Proc Soc Exp Biol Med (1997) 0.92
Evidence for activin A and follistatin involvement in the systemic inflammatory response. Mol Cell Endocrinol (2001) 0.91
Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol (2002) 0.89
Diabetes microvascular complications in prepubertal children. J Pediatr Endocrinol Metab (1998) 0.86
Renal structural-functional relationships in early diabetes mellitus. Pediatr Nephrol (1997) 0.84
Rat follistatin: gonadal and extragonadal expression and evidence for alternative splicing. Biochem Biophys Res Commun (1990) 0.84
Activin A and follistatin: their role in the acute phase reaction and inflammation. J Endocrinol (1999) 0.83
Puberty permits increased expression of renal transforming growth factor-beta1 in experimental diabetes. Pediatr Nephrol (2001) 0.83
Determinants of progression of microalbuminuria in adolescents with IDDM. Diabetes Care (1996) 0.82
Immunohistochemical localization of follistatin in rat tissues. Endocrinol Jpn (1991) 0.81
Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes (1990) 0.81
Progression to end-stage renal disease in children with posterior urethral valves. Pediatr Nephrol (1998) 0.80
Dissociation of renal TGF-beta and hypertrophy in female rats with diabetes mellitus. Am J Physiol Renal Physiol (2004) 0.79
Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat. Diabetes Res (1994) 0.79
Follistatin steady state messenger ribonucleic acid levels in confluent cultures of a rat renal mesangial cell line are regulated by multiple factors. Endocrinology (1992) 0.79
Streptozocin diabetes elevates all isoforms of TGF-beta in the rat kidney. Int J Exp Diabetes Res (2001) 0.78
Rat follistatin: ontogeny of steady-state mRNA levels in different tissues predicts organ-specific functions. Biochem Biophys Res Commun (1991) 0.77
Diabetic glomerulopathy in young IDDM patients. Preventive and diagnostic aspects. Horm Res (1998) 0.77
Followup study of renal function in children with reflux nephropathy after resolution of vesicoureteral reflux. J Urol (1997) 0.77
Diabetes-related renal growth and IGF-I accumulation in castrated rats. Diabetes Res Clin Pract (1991) 0.76
Age of onset of streptozocin diabetes determines the renal structural response in the rat. Pediatr Res (1997) 0.76
Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int (1995) 0.76
Inhibins, activins and follistatins: a review of complex regulators of the reproductive system. Eur J Contracept Reprod Health Care (1998) 0.76
Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat. Diabetes (1992) 0.76
Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol (2006) 1.63
Renal fluid and electrolyte handling in BKCa-beta1-/- mice. Am J Physiol Renal Physiol (2003) 1.06
Glycemic control over 3 years in a young adult clinic for patients with type 1 diabetes. Diabetes Res Clin Pract (2007) 1.01
Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int J Exp Diabetes Res (2002) 0.98
Estrogen receptor alpha-mediated events promote sex-specific diabetic glomerular hypertrophy. Am J Physiol Renal Physiol (2004) 0.96
PP2B-dependent NO production in the medullary thick ascending limb during diabetes. Am J Physiol Renal Physiol (2009) 0.95
Uteroplacental insufficiency affects kidney VEGF expression in a model of IUGR with compensatory glomerular hypertrophy and hypertension. Early Hum Dev (2009) 0.95
PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats. Am J Physiol Renal Physiol (2009) 0.94
Posttranslational regulation of NO synthase activity in the renal medulla of diabetic rats. Am J Physiol Renal Physiol (2004) 0.92
Protein kinase C-dependent NAD(P)H oxidase activation induced by type 1 diabetes in renal medullary thick ascending limb. Hypertension (2009) 0.91
Classical estrogen receptors and ERα splice variants in the mouse. PLoS One (2013) 0.91
Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats. Am J Physiol Renal Physiol (2007) 0.90
Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney. Am J Physiol Renal Physiol (2008) 0.87
Compensatory kidney growth in estrogen receptor-alpha null mice. Am J Physiol Renal Physiol (2005) 0.87
Src family kinase involvement in rat preglomerular microvascular contractile and [Ca2+]i responses to ANG II. Am J Physiol Renal Physiol (2004) 0.86
Tempol prevents altered K(+) channel regulation of afferent arteriolar tone in diabetic rat kidney. Hypertension (2012) 0.85
NOS3 regulation: renal tubular epithelial cells are not simply large endothelial cells. Hypertension (2005) 0.83
NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes. Hypertension (2011) 0.83
Diabetic nephropathy: nitric oxide and renal medullary hypoxia. Am J Physiol Renal Physiol (2007) 0.82
The administrative colloquium: developing management and leadership skills for faculty. Ambul Pediatr (2004) 0.80
Angiotensin II triggers EGFR tyrosine kinase-dependent Ca2+ influx in afferent arterioles. Hypertension (2002) 0.80
High glucose augments arginase activity and nitric oxide production in the renal cortex. Metabolism (2004) 0.80
A broader view of animal research. BMJ (2007) 0.80
Dissociation of renal TGF-beta and hypertrophy in female rats with diabetes mellitus. Am J Physiol Renal Physiol (2004) 0.79
Renal cortical nitric oxide synthase activity during maturational growth in the rat. Pediatr Nephrol (2002) 0.78
Acute effects of different intensities of exercise in normoalbuminuric/normotensive patients with type 1 diabetes. Diabetes Care (2004) 0.77
Relative contributions of Ca2+ mobilization and influx in renal arteriolar contractile responses to arginine vasopressin. Am J Physiol Renal Physiol (2004) 0.77
Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats. Clin Sci (Lond) (2013) 0.77
Impact of angiotensin-converting enzyme inhibition on renal cortical nitrotyrosine content during increased extracellular glucose concentration. Clin Biochem (2006) 0.76
Clinical challenges in vulnerable CKD populations. Adv Chronic Kidney Dis (2008) 0.75